Ameet Mallik finds greener turf as new head of ADC Therapeutics following ill-fated first CEO stint - Endpoints News

Around a year ago, Ameet Mallik left his post at Novartis, where he had spent the last 16 years, to champion a drug for metastatic pancreatic cancer as CEO at Rafael Holdings. However, just half a year in, the company took a nosedive as that drug failed a Pha…

Clay Siegall, the co-founder and longtime CEO of Seagen, is on a leave of absence following an alleged incident of domestic violence, the company revealed Monday morning. While Siegall — who informe… [+569 chars]

full article...